- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | EuroAPI vaults operating chief into CEO role as it embarks upon 'new chapter' | ||
| Mo | Boehringer, Lilly bring 'It Takes 2' kidney disease testing push to 2025 Rose Parade | ||
| Mo | BioMarin to add €60M lab to Irish manufacturing site in push to grow production capacity | ||
| Mo | ASH: Catching up with bispecific rival AbbVie, Roche's subcutaneous Lunsumio matches IV version in lymphoma | ||
| Mo | ASH: With survival win against J&J's Darzalex, GSK bolsters case for return of myeloma ADC Blenrep | ||
| Mo | AbbVie survey singles out emotional impact of CLL diagnosis on Black, Hispanic and Asian patients | ||
| Mo | Biosecure Act MIA from US defense bill in key win for China biopharma service providers | ||
| Mo | Amgen's Blincyto keeps 96% of pediatric leukemia patients alive and disease-free in 'practice changing' 3-year study | ||
| Mo | Merck gets rare win with Keytruda-Lynparza combo but role of Keytruda in ovarian cancer 'remains uncertain' | ||
| Mo | Omnicom, Interpublic ink merger to create world's largest ad agency | ||
| Mo | Acadia nabs Lexicon, Bristol Myers Squibb veteran as new commercial lead | ||
| So | ASH: AstraZeneca proposes fixed-duration Calquence combos in chronic lymphocytic leukemia | ||
| Fr | GSK's ViiV Healthcare encourages deeper conversations about life with HIV in video series | ||
| Fr | With green light from European Commission, Novo Holdings' proposed $16.5B Catalent buyout nears close | ||
| Fr | CDMO Resilience plots 105 layoffs at Florida plant it acquired in 2021 | ||
| Fr | Novo Nordisk slashes prices of additional insulin products but not until 2026 | ||
| Fr | Pfizer, Eli Lilly and PhRMA CEOs joined Trump for Mar-a-Lago dinner to talk collaboration, cures for cancer: Axios | ||
| Fr | Teva, Takeda sell generics joint venture in Japan to focus on innovative drugs | ||
| Fr | Employees' LinkedIn likes land AstraZeneca and GSK in hot water | ||
| Fr | PharmaEssentia nabs MorphoSys GM Horvat to lead its commercial team | ||
| Fr | AbbVie's Skyrizi retains DTC spending crown, as Novo's Wegovy sees first entry | ||
| Fr | Fierce Pharma Asia-Sanofi's $1B manufacturing base; GSK's ADC deal, Shingrix recalibration in China | ||
| Do | On an investment spree, Lilly will spend $3B to expand newly acquired injectables plant in Wisconsin | ||
| Do | Novartis' latest attempt to fend off MSN's Entresto generic falls short on appeal | ||
| Do | AstraZeneca scores FDA nod for Imfinzi as first immunotherapy for limited-stage small cell lung cancer |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
